The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Abstract

Blockade of aldosterone receptors by spironolactone, in addition to standard therapy, substantially reduces the risk of both morbidity and death among patients with severe heart failure.